Loading clinical trials...
Loading clinical trials...
An Open-label Study of the Efficacy and Safety of SYNB1618 and SYNB1934 in Patients With Phenylketonuria (SynPheny-1)
Conditions
Interventions
SYNB1618
SYNB1934
Locations
11
United States
Children's Hospital Colorado
Aurora, Colorado, United States
Excel Medical Clinical Trials, LLC
Boca Raton, Florida, United States
University of Florida College of Medicine
Gainesville, Florida, United States
Washington University in St Louis
St Louis, Missouri, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Oregon Health and Science University
Portland, Oregon, United States
Start Date
August 25, 2020
Primary Completion Date
October 7, 2022
Completion Date
October 7, 2022
Last Updated
October 17, 2022
NCT06628128
NCT06971731
NCT05579548
NCT06560736
NCT06332807
NCT06780332
Lead Sponsor
Synlogic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions